DATA COMMITTEE FINDS ‘HIGH LEVEL OF TREATMENT SUCCESS’
Amplyx Adds to Pipeline, Unveils Clinical Trial Data
Sunday, September 22, 2019
Amplyx Pharmaceuticals recently revealed promising data for a drug designed to treat life-threatening infections, while the San Diego biotech separately licensed a drug from pharmaceutical Novartis...
Take 1 minute to subscribe and you'll get this story immediately, plus:
Already a subscriber? Sign in
- 52 weekly issues
- Subscriber-only digital content every business day, plus full access to SDBJ.com archives
- Book of Lists — the most comprehensive business resource in San Diego
- San Diego 500 — influential business leaders you need to know